Company News

Share this article:

Merck inked a deal with insurance carrier Cigna to provide discounted Januvia and Janumet – both anti-diabetes medications – to Cigna customers based on drug adherence and results. If a given Cigna customer successfully lowers his or her blood sugar on Januvia and Janumet, Cigna will get a discount on the drugs. Additionally, Cigna patients adhering to their Januvia or Janumet regimens will provide the insurer with further discounts, according to a company statement.

 

Roche Madison, a Hoffman-La Roche RNA therapeutics unit, has moved into its new chemistry and biology lab facilities in Madison, Wisconsin's research park. Roche Madison is the result of Roche's purchase of Mirus Bio Corporation in 2008. The site currently employs 45, and plans to hire additional staff over the next year.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.